Navigation Links
Assurex Health Announces International Expansion through Canadian Partnership with the Centre for Addiction and Mental Health
Date:11/19/2013

MASON, Ohio, Nov. 19, 2013 /PRNewswire/ -- Assurex Health, a leading personalized medicine company focused on neuropsychiatric disorders, today announced the company's first public-private partnership with the Centre for Addiction and Mental Health (CAMH), one of the world's leading research centers in the area of addiction and mental health and Canada's largest mental health teaching hospital.  This joint venture forms AssureRx Canada, Ltd., marking the first international expansion for Assurex Health.  The venture expands the use of GeneSight®, a personalized medicine technology that analyzes a patient's DNA to provide clinicians with an individualized report to help select appropriate treatments for depression, anxiety, bipolar, schizophrenia, ADHD, and chronic pain.

(Logo:  http://photos.prnewswire.com/prnh/20130910/CL75944LOGO)

This partnership has the potential to help millions of Canadians with mental illness avoid trial and error medication prescribing, which is an unfortunate reality for many patients.  Recent studies show that only 30% of patients are prescribed a genetically appropriate medication the first time. This is costly to the health care system and to patients who suffer lost productivity, higher absenteeism, and family/relationship issues. With up to 60 million people in the US and Canada taking a psychotropic, ADHD, or analgesic medication, the North American neuropsychiatric pharmacogenomics market is estimated to be in excess of $4 billion.

Assurex Health has a proven track record in the U.S. with its GeneSight panel, a test reimbursed by a number of insurance companies as well as Medicare and Medicaid. In the U.S., Assurex Health data shows a 70% improvement in depressive symptoms when GeneSight testing is used to predict
'/>"/>

SOURCE Assurex Health
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Assurex Health Appoints Veteran P&G Consumer Products Executive Virginia Coleman Drosos President to Lead Personalized Medicine Growth
2. Assurex Health Appoints Chief Financial Officer and Payer Market Executive to Manage Rapid Growth in Personalized Medicine
3. As Affordable Care Act Sputters out of the Gate, Medicationdiscountcard.com Offers Survival Tips for Those Forgoing Health Insurance Coverage in 2014
4. Pharmspective Launches Affordable Care Act eLearning for Healthcare Decision-Makers
5. HDMAs Gray: Passage Of National Pharmaceutical Traceability Legislation A Critical Accomplishment For Healthcare Industry And Patients
6. GW Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
7. LDV 2014 Harmony Mobile Womens Health On Display At RSNA
8. CVS Caremark Names Tracy Bahl as Executive Vice President, Health Plans
9. CareFusion To Acquire Vital Signs Division of GE Healthcare For $500 Million
10. ANI Pharmaceuticals To Present At Oppenheimer 24th Annual Healthcare Conference On December 10, 2013
11. mHealth market is Expected to Reach $58.8 Billion Globally by 2020 According to Allied Market Research Projections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ) ... to Prepare Application Dossiers for Oversea Medical device ... report to their offering. The ... market of the most growth potentiality, which is ... and producers to penetrate such market. It is ...
(Date:5/22/2015)... 22, 2015 Research and Markets ... the "Latest Regulations on Pharmaceutical International Multi-Center ... offering. This is first time in ... on international multi-center clinical trials of drugs in ... to be implemented on March 1, 2015. The ...
(Date:5/22/2015)... a sweeping analysis assessing the current state of diabetes ... conclude that there remains considerable room for improving treatment ... but especially for adolescents and young adults. The analysis ... the need to address barriers to care and implement ... patients achieve optimal metabolic control. The ...
Breaking Medicine Technology:China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 32015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... Oct. 29 Amicus Therapeutics (Nasdaq: FOLD ... today, October 29, 2010 at 8:30 a.m. Eastern Time ... PLC to develop and commercialize Amigal (migalastat HCl) for ... and investors may access the conference call today at ...
... CHICAGO, Oct. 29 New data presented today at ... (EHMTIC) shows that persons with chronic migraine (headache on ... are much more likely to have annual household incomes ... < 15 days per month).  This difference in household ...
Cached Medicine Technology:Chronic Migraine Is Associated With Reduced Household Income and Greater Headache Impact 2Chronic Migraine Is Associated With Reduced Household Income and Greater Headache Impact 3
(Date:5/22/2015)... (PRWEB) May 22, 2015 River Valley ... Kyle Johnson, the health system’s Chief Financial Officer (CFO), ... Johnson has served as the company CFO since 2011. ... will be joining the health system as CFO. Wesley ... interim basis, while the Board of Trustees conducts a ...
(Date:5/22/2015)... UK (PRWEB) May 22, 2015 ... leading treatment option for chronic obstructive pulmonary disorder ... GlaxoSmithKline plc and AstraZeneca plc as well as ... market share and position. But will market payers, ... the already well-entrenched products to completely new ones? ...
(Date:5/22/2015)... 22, 2015 Carnegie Science Center ... announced a new partnership to develop BodyTech, a dynamic, ... The initiative includes a new exhibit at the Science ... theater, and a new traveling science show, Anatomy Adventure, ... 2015. , Designed to explore a wide range ...
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship ... Drobeck is in his second year of racing in the ... Missoula Fire Department in Missoula, MT. He entered the triathlon ... his career, he has had 15 1st Place finishes. In ... finishes in all seven of his 2014 races, including two ...
(Date:5/22/2015)... CA (PRWEB) May 22, 2015 ... Sunset Plaza Dental announces that they are now ... restorative and other dental treatments. At consultations, patients ... them. Questions regarding what certain treatments can achieve ... be covered during this initial appointment. If treatments ...
Breaking Medicine News(10 mins):Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2
... less-affluent families are at higher risk, study finds , TUESDAY, ... who have child care may suffer from a higher rate ... affluent families, new research suggests. , In the report, published ... Community Health , researchers looked at a study of 14,000 ...
... , TUESDAY, Nov. 24 (HealthDay News) -- Strains ... are increasingly showing up among hospital outpatients, raising ... research says. , From 1999 to 2006, researchers ... outpatients with methicillin-resistant Staphylococcus aureus (MRSA) ...
... ... the Academic and Research Communities , ... (PRWEB) -- Ziosoft®, Inc. a leader in advanced visualization and analysis ... the academic and research communities. The Windows®-based software can be used for reviewing ...
... ... with Stem Cell Therapy. , ... San Diego, CA (PRWEB) November 24, 2009 -- Entest Biomedical, Inc. (OTCBB: ENTB) ... a proprietary laser device which shall be owned by Entest and used in conjunction with ...
... ... doctors in providing proven, non-surgical relief to millions of sufferers. , ... Dallas, TX (PRWEB) November 24, 2009 ... Frozen Shoulder Syndrome Diagnosis & Treatment seminar dates today. The three-day training seminars ...
... ... American Podiatric Medical Association , ... Bethesda, Md. (Vocus) November 24, 2009 -- The average person walks between 8,000-10,000 steps a ... continue making their holiday travel plans, it’s easy to forget that the feet often bear ...
Cached Medicine News:Health News:MRSA Creeping Into Hospitals From the Outside 2Health News:MRSA Creeping Into Hospitals From the Outside 3Health News:Ziosoft Releases Free zioTerm Basic 2D/3D Software Application 2Health News:Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 3Health News:Keep Holiday Travel Foot-Friendly 2Health News:Keep Holiday Travel Foot-Friendly 3
Inquire...
The essence of fluorescence analysis is sensitivity. The high throughput optical system in the RF-5301PC employs a blazed holographic grating, photomultiplier and digital signal processing to provide...
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications....
... 200 is a fixed wavelength fluorometer ... nm emission. The spectral characteristics are ... double-stranded DNA using the standard Hoechst ... interference from the presence of protein, ...
Medicine Products: